Guillermo E. Umpierrez mostly deals with Diabetes mellitus, Internal medicine, Type 2 diabetes, Insulin and Endocrinology. His work deals with themes such as Surgery, Pediatrics and Intensive care medicine, which intersect with Diabetes mellitus. His research investigates the connection between Internal medicine and topics such as Gastroenterology that intersect with problems in Odds ratio.
His work carried out in the field of Type 2 diabetes brings together such families of science as Randomized controlled trial, Glycemic and Type 2 Diabetes Mellitus. His Insulin research includes themes of Anesthesia and Cytokine. His research integrates issues of Alternative medicine, Placebo and Health professionals in his study of Endocrinology.
Diabetes mellitus, Internal medicine, Type 2 diabetes, Insulin and Endocrinology are his primary areas of study. His studies deal with areas such as Randomized controlled trial and Intensive care medicine as well as Diabetes mellitus. His Insulin resistance study in the realm of Internal medicine interacts with subjects such as In patient.
Guillermo E. Umpierrez interconnects Basal, Regimen and Gerontology in the investigation of issues within Type 2 diabetes. His Insulin study incorporates themes from Anesthesia, Clinical trial and Surgery. The study incorporates disciplines such as Ketoacidosis, Type 1 diabetes and Pediatrics in addition to Diabetic ketoacidosis.
Guillermo E. Umpierrez spends much of his time researching Diabetes mellitus, Internal medicine, Type 2 diabetes, Hypoglycemia and Insulin. His research in Diabetes mellitus intersects with topics in Emergency medicine and Intensive care medicine. His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology, Placebo and Endocrinology.
His study in Type 2 diabetes is interdisciplinary in nature, drawing from both Basal, Regimen, Randomized controlled trial and Continuous glucose monitoring. His work is dedicated to discovering how Hypoglycemia, Point of care are connected with Glucose testing and other disciplines. His work on Metformin and Stress hyperglycemia as part of general Insulin research is frequently linked to Sliding scale, bridging the gap between disciplines.
Guillermo E. Umpierrez mainly focuses on Diabetes mellitus, Hypoglycemia, Internal medicine, Type 2 diabetes and Glycemic. His studies in Diabetes mellitus integrate themes in fields like Placebo, Intensive care unit and Renal function. His study on Hypoglycemia also encompasses disciplines like
His work in the fields of Internal medicine, such as Insulin, Retrospective cohort study and End stage renal disease, overlaps with other areas such as In patient. Guillermo E. Umpierrez has included themes like Management algorithm, Regimen and Randomized controlled trial in his Type 2 diabetes study. His Glycemic research is multidisciplinary, incorporating elements of Kidney disease and Intensive care medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Hyperglycemia: An Independent Marker of In-Hospital Mortality in Patients with Undiagnosed Diabetes
Guillermo E. Umpierrez;Scott D. Isaacs;Niloofar Bazargan;Xiangdong You.
The Journal of Clinical Endocrinology and Metabolism (2002)
Hyperglycemic Crises in Adult Patients With Diabetes
Abbas E. Kitabchi;Guillermo E. Umpierrez;John M. Miles;Joseph N. Fisher.
Diabetes Care (2009)
Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: An Endocrine Society Clinical Practice Guideline
Guillermo E. Umpierrez;Richard Hellman;Mary T. Korytkowski;Mikhail Kosiborod.
The Journal of Clinical Endocrinology and Metabolism (2012)
AACE comprehensive diabetes management algorithm 2013.
Alan J. Garber;Martin J. Abrahamson;Joshua I. Barzilay;Lawrence Blonde.
Endocrine Practice (2013)
Management of Hyperglycemic Crises in Patients With Diabetes
Abbas E. Kitabchi;Guillermo E. Umpierrez;Mary Beth Murphy;Eugene J. Barrett.
Diabetes Care (2001)
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
Vlad Ratziu;Vlad Ratziu;Stephen A. Harrison;Sven Francque;Pierre Bedossa.
Gastroenterology (2016)
American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.
Etie S. Moghissi;Mary T. Korytkowski;Monica DiNardo;Daniel Einhorn.
Endocrine Practice (2009)
Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial).
Guillermo E. Umpierrez;Dawn Smiley;Ariel Zisman;Luz M. Prieto.
Diabetes Care (2007)
American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015.
Yehuda Handelsman;Zachary T. Bloomgarden;George Grunberger;Guillermo Umpierrez.
Endocrine Practice (2015)
Randomized Study of Basal Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery)
Guillermo Umpierrez;Dawn Smiley;Sol Jacobs;Limin Peng.
Diabetes Care (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Tennessee Health Science Center
Yale University
University of Washington
University of Copenhagen
Emory University
SUNY Upstate Medical University
University of Leicester
Università Campus Bio-Medico
Finnish Institute for Health and Welfare
Emory University
Colorado State University
Indiana University – Purdue University Indianapolis
German Aerospace Center
Projekt202
IBM (United States)
Heriot-Watt University
University of Bayreuth
Kyushu University
Dalian University of Technology
California Institute of Technology
Technical University of Munich
American School of Classical Studies at Athens
University of Paris-Saclay
Albert Einstein College of Medicine
University of California, San Francisco
Chinese Academy of Sciences